If you do one thing for body composition on a GLP-1 besides eating protein, lift. The evidence is not GLP-1-specific, because no large trial has yet randomised people on semaglutide or tirzepatide to lift or not. It is the evidence from every other kind of weight loss, and there is no reason to think this one is different.
What is being asked
The US Physical Activity Guidelines (2018) and the WHO guidelines (2020) both call for muscle-strengthening activity of moderate or greater intensity involving all major muscle groups on two or more days a week, in addition to 150 to 300 minutes of moderate aerobic activity (PubMed 30418471; PubMed 33239350). The 2025 GLP-1 joint advisory goes further for people on therapy: regular strength training at least three times weekly plus at least 150 minutes of moderate aerobic exercise (PubMed 40445127). The step up reflects the DXA findings: a quarter or more of the weight lost on these drugs was lean tissue in the substudies, and resistance training is the intervention that changes that share.
What the evidence shows it does
- During weight loss, lifting keeps lean mass. In Villareal's trial of 160 older adults with obesity on a weight-loss programme, all exercise groups lost about 9 percent of body weight, but lean mass fell less in the resistance and combined groups than in the aerobic group, and bone density was better preserved too (PubMed 28514618). See exercise plus GLP-1 trials for the details.
- Protein makes it work better, up to a point. Morton's meta-analysis of 49 trials found protein supplementation added about 0.3 kg of fat-free mass to what resistance training alone produced, with no further benefit above about 1.6 g/kg/day (PubMed 28698222). The protein guide has the ranges.
- Strength is a health outcome in its own right. The primary outcome in Villareal was physical performance, and the combination of resistance and aerobic training improved it most. Muscle you can use matters more than muscle you can measure.
A starting programme
Not a prescription; a template that meets the guidelines and that most adults can begin with body weight or light dumbbells. If you have a heart condition, joint replacement, uncontrolled blood pressure or any condition where exertion has been restricted, ask your clinician first.
Frequency: two days a week to start, three once it is routine, with at least one rest day between sessions.
The session (30 to 40 minutes):
| Movement pattern | Example exercises (easier to harder) | Sets x reps |
|---|---|---|
| Squat | Sit-to-stand from a chair, goblet squat, barbell squat | 2 to 3 x 8 to 12 |
| Hinge | Hip bridge, Romanian deadlift with dumbbells, deadlift | 2 to 3 x 8 to 12 |
| Push | Wall or incline push-up, floor push-up, dumbbell press | 2 to 3 x 8 to 12 |
| Pull | Band row, dumbbell row, lat pulldown | 2 to 3 x 8 to 12 |
| Carry or core | Farmer's carry, plank, dead bug | 2 x 30 to 45 seconds |
Effort: the last two repetitions of each set should be hard but controlled, with a couple left in reserve. Rest 60 to 120 seconds between sets.
Progression: when you can do 12 repetitions on all sets with good form, add weight (the smallest step available) or move to the harder version and drop back to 8. That single rule, applied every week, is progressive overload. Write down what you lifted; the log is also your body composition measure.
Notes specific to being on a GLP-1
- Fuel. Appetite suppression means many people train under-fuelled without noticing. A protein-containing meal or shake within a couple of hours before and after the session covers both the training and the daily target. Do not train fasted on purpose during the escalation months.
- Nausea. Common during dose escalation (the Wegovy label reports it in 44 percent of participants versus 16 percent on placebo). Lifting is usually better tolerated than running when nauseated; see exercise when nauseated.
- Fluids. The labels warn of acute kidney injury with dehydration from gastrointestinal effects. Drink before and after; see hydration and fibre.
- Glucose. If you take insulin or a sulfonylurea alongside the GLP-1, the labels warn of hypoglycaemia; exercise adds to it. Ask your prescriber about monitoring around sessions.
- Rapid loss and joints. Losing weight fast unloads joints but also changes movement patterns. Progress load slowly and keep form strict.
- Dizziness. Lower blood pressure and lower intake together make standing up fast from a hinge or squat a moment to be careful about. Stand slowly; sit if light-headed.
Where to go from here
Two or three sessions a week of the template above, protein at the target, weekly weighing done properly, and a monthly waist measurement will give you, in three months, a clear answer to the question the scale cannot: how much of what you lost was fat. The sibling site FormBlends Guides covers the practicalities of muscle preservation alongside injection technique and travel; the maintenance guide explains why this habit matters most after the drug.
Questions people ask
Do I need a gym?
No. Body weight, a pair of adjustable dumbbells or resistance bands cover every movement in the starting programme. A gym makes progression easier once body weight is no longer enough, which for lower-body movements happens fairly soon.
Will lifting stop the scale from moving?
It can slow it in the first weeks as muscle glycogen and water increase, and over months if you gain muscle while losing fat. Both are good outcomes the scale reads as bad. Measure your waist monthly and log your lifts; see body composition measures.
Sources
- Piercy KL et al. The Physical Activity Guidelines for Americans. JAMA 2018. PubMed 30418471 Accessed September 4, 2026.
- Bull FC et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med 2020. PubMed 33239350 Accessed September 4, 2026.
- Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory. Obesity 2025. PubMed 40445127 Accessed September 4, 2026.
- Morton RW et al. Protein supplementation and resistance training-induced gains in muscle mass and strength: systematic review and meta-analysis. Br J Sports Med 2018. PubMed 28698222 Accessed September 4, 2026.
- Villareal DT et al. Aerobic or resistance exercise, or both, in dieting obese older adults. N Engl J Med 2017. PubMed 28514618 Accessed September 4, 2026.
- Wegovy (semaglutide) prescribing information, NDA 215256, Drugs@FDA Accessed September 4, 2026.
Canonical URL: https://formblendsweightloss.com/training/resistance-training-basics. Written by the FormBlends editorial team. This page is educational and is not medical advice; see the medical disclaimer.